U.S. flag

An official website of the United States government

NM_000397.4(CYBB):c.607G>T (p.Glu203Ter) AND Granulomatous disease, chronic, X-linked

Germline classification:
Pathogenic/Likely pathogenic (2 submissions)
Last evaluated:
Aug 14, 2018
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000029630.10

Allele description [Variation Report for NM_000397.4(CYBB):c.607G>T (p.Glu203Ter)]

NM_000397.4(CYBB):c.607G>T (p.Glu203Ter)

Gene:
CYBB:cytochrome b-245 beta chain [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xp21.1
Genomic location:
Preferred name:
NM_000397.4(CYBB):c.607G>T (p.Glu203Ter)
HGVS:
  • NC_000023.11:g.37796074G>T
  • NG_009065.1:g.21054G>T
  • NM_000397.4:c.607G>TMANE SELECT
  • NP_000388.2:p.Glu203Ter
  • NP_000388.2:p.Glu203Ter
  • LRG_53t1:c.607G>T
  • LRG_53:g.21054G>T
  • LRG_53p1:p.Glu203Ter
  • NC_000023.10:g.37655327G>T
  • NM_000397.3:c.607G>T
  • p.Glu203X
Protein change:
E203*
Links:
dbSNP: rs193922449
NCBI 1000 Genomes Browser:
rs193922449
Molecular consequence:
  • NM_000397.4:c.607G>T - nonsense - [Sequence Ontology: SO:0001587]
Observations:
1

Condition(s)

Name:
Granulomatous disease, chronic, X-linked
Synonyms:
CYTOCHROME b-NEGATIVE GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; GRANULOMATOUS DISEASE, CHRONIC, X-LINKED, SOMATIC MOSAIC
Identifiers:
MONDO: MONDO:0010600; MedGen: C1844376; Orphanet: 379; OMIM: 306400

Recent activity

  • RecName: Full=E3 ubiquitin-protein ligase Topors; AltName: Full=RING-type E3 ubi...
    RecName: Full=E3 ubiquitin-protein ligase Topors; AltName: Full=RING-type E3 ubiquitin transferase Topors; AltName: Full=SUMO1-protein E3 ligase Topors; AltName: Full=Topoisomerase I-binding RING finger protein; AltName: Full=Topoisomerase I-binding arginine/serine-rich protein; AltName: Full=Tumor suppressor p53-binding protein 3; Short=p53-binding protein 3; Short=p53BP3
    gi|74752935|sp|Q9NS56.1|TOPRS_HUMAN
    Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000052282Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
likely pathogenic
(Aug 18, 2011)
germlinecuration, clinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link,

SCV000943366Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Aug 14, 2018)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot provided1not providedcuration
not providedgermlineunknown1not providednot providednot providednot providedclinical testing

Citations

PubMed

Hematologically important mutations: X-linked chronic granulomatous disease (second update).

Heyworth PG, Curnutte JT, Rae J, Noack D, Roos D, van Koppen E, Cross AR.

Blood Cells Mol Dis. 2001 Jan-Feb;27(1):16-26. No abstract available.

PubMed [citation]
PMID:
11162142

X-CGDbase: a database of X-CGD-causing mutations.

Roos D.

Immunol Today. 1996 Nov;17(11):517-21. No abstract available.

PubMed [citation]
PMID:
8961628
See all PubMed Citations (6)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000052282.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedcuration PubMed (3)
2not providednot providednot providednot providedclinical testing PubMed (3)

Description

"X-CGD; controls not tested."

Description

Converted during submission to Likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided
2germlineunknownnot providedBloodassert pathogenicitynot providednot providednot provided See 2

Co-occurrences

#ZygosityAllelesNumber of Observations
2HomozygoteCYBB:c.1002G>A1

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000943366.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change creates a premature translational stop signal (p.Glu203*) in the CYBB gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individuals affected with chronic granulomatous disease (PMID: 8634410, 20729109). ClinVar contains an entry for this variant (Variation ID: 35974). Loss-of-function variants in CYBB are known to be pathogenic (PMID: 9585602, 20729109). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024